Literature DB >> 19627427

Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities.

P Oliver-Africano1, S Dickens, Z Ahmed, N Bouras, S Cooray, S Deb, M Knapp, M Hare, M Meade, B Reece, S Bhaumik, D Harley, J Piachaud, A Regan, D Ade Thomas, S Karatela, B Rao, T Dzendrowskyj, L Lenôtre, J Watson, P Tyrer.   

Abstract

BACKGROUND: Aggressive challenging behaviour in people with intellectual disability (ID) is frequently treated with antipsychotic drugs, despite a limited evidence base.
METHOD: A multi-centre randomised controlled trial was undertaken to investigate the efficacy, adverse effects and costs of two commonly prescribed antipsychotic drugs (risperidone and haloperidol) and placebo.
RESULTS: The trial faced significant problems in recruitment. The intent was to recruit 120 patients over 2 years in three centres and to use a validated aggression scale (Modified Overt Aggression Scale) score as the primary outcome. Despite doubling the period of recruitment, only 86 patients were ultimately recruited.
CONCLUSIONS: Variation in beliefs over the efficacy of drug treatment, difficulties within multidisciplinary teams and perceived ethical concerns over medication trials in this population all contributed to poor recruitment. Where appropriate to the research question cluster randomised trials represent an ethically and logistically feasible alternative to individually randomised trials.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19627427     DOI: 10.1111/j.1365-2788.2009.01195.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  5 in total

1.  Primary care of adults with developmental disabilities: Canadian consensus guidelines.

Authors:  William F Sullivan; Joseph M Berg; Elspeth Bradley; Tom Cheetham; Richard Denton; John Heng; Brian Hennen; David Joyce; Maureen Kelly; Marika Korossy; Yona Lunsky; Shirley McMillan
Journal:  Can Fam Physician       Date:  2011-05       Impact factor: 3.275

2.  Interest in Research Participation Among Caregivers of Children with Neurodevelopmental Disorders.

Authors:  L Kalb; L Jacobson; C Zisman; E Mahone; R Landa; G Azad; D Menon; V Singh; A Zabel; A Pritchard
Journal:  J Autism Dev Disord       Date:  2019-09

3.  Social validity of randomised controlled trials in health services research and intellectual disabilities: a qualitative exploration of stakeholder views.

Authors:  Dan Robotham; Michael King; Anton Canagasabey; Sophie Inchley-Mort; Angela Hassiotis
Journal:  Trials       Date:  2011-06-09       Impact factor: 2.279

4.  Aggression Following Traumatic brain injury: Effectiveness of Risperidone (AFTER): study protocol for a feasibility randomised controlled trial.

Authors:  Shoumitro Deb; Verity Leeson; Lina Aimola; Mayur Bodani; Lucia Li; Tim Weaver; David Sharp; Mike Crawford
Journal:  Trials       Date:  2018-06-21       Impact factor: 2.279

5.  Expanding capacity in mental health research in intellectual disabilities.

Authors:  Angela Hassiotis; Peter Langdon; Ken Courtenay; Ian Hall; Bryn Lloyd-Evans; Renee Romeo; Athanasia Kouroupa; Vicky Crossey; Laurence Taggart
Journal:  BJPsych Bull       Date:  2021-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.